Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment
ACS Nano · 30.04.2024 · 18 (17) · 11025-11041
DOI: 10.1021/acsnano.3c08335 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 16.04.2024. Verfasst von Natalie K Horvat und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Im Neuenheimer Feld 350, 69120, Heidelberg,…. Hauptthemen laut MEDLINE: Lung Neoplasms, Tumor Microenvironment, Magnetic Iron Oxide Nanoparticles, Crizotinib. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medizinischen Fakult?t Heidelberg, Universit?t Heidelberg, European Hematology Association, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
ALK-positive NSCLC patients demonstrate initial responses to ALK tyrosine kinase inhibitor (TKI) treatments, but eventually develop resistance, causing rapid tumor relapse and poor survival rates. Growing evidence suggests that the combination of drug and immune therapies greatly improves patient survival; however, due to the low immunogenicity of the tumors, ALK-positive patients do not respond to currently available immunotherapies. Tumor-associated macrophages (TAMs) play a crucial role in facilitating lung cancer growth by suppressing tumoricidal immune activation and absorbing chemotherapeutics. However, they can also be programmed toward a pro-inflammatory tumor suppressive phenotype, which represents a highly active area of therapy development. Iron loading of TAMs can achieve such reprogramming correlating with an improved prognosis in lung cancer patients. We previously showed that superparamagnetic iron oxide nanoparticles containing core-cross-linked polymer micelles (SPION-CCPMs) target macrophages and stimulate pro-inflammatory activation. Here, we show that SPION-CCPMs stimulate TAMs to secrete reactive nitrogen species and cytokines that exert tumoricidal activity. We further show that SPION-CCPMs reshape the immunosuppressive Eml4-Alk lung tumor microenvironment (TME) toward a cytotoxic profile hallmarked by the recruitment of CD8+ T cells, suggesting a multifactorial benefit of SPION-CCPM application. When intratracheally instilled into lung cancer-bearing mice, SPION-CCPMs delay tumor growth and, after first line therapy with a TKI, halt the regrowth of relapsing tumors. These findings identify SPIONs-CCPMs as an adjuvant therapy, which remodels the TME, resulting in a delay in the appearance of resistant tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany.
- Molecular Medicine Partnership Unit (MMPU), Otto-Meyerhof-Zentrum, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany.
- Ruprecht Karl University of Heidelberg, 69120, Heidelberg, Germany.
- Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
- Leiden Academic Centre for Drug Research (LACDR), Leiden University, Einsteinweg 55, 2333CC, Leiden, The Netherlands.
- Division of Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
ORCID-Profile: Lu Su, Matthias Barz, Martina U Muckenthaler
Förderung
- Medizinischen Fakult?t Heidelberg, Universit?t Heidelberg
- European Hematology Association
- Deutsche Forschungsgemeinschaft
- Deutsches Zentrum f?r Lungenforschung
Zitieren
APA
Horvat, N. K., Chocarro, S., Marques, O., Bauer, T. A., Qiu, R., Diaz-Jimenez, A., Helm, B., Chen, Y., Sawall, S., Sparla, R., Su, L., Klingmüller, U., Barz, M., Hentze, M. W., Sotillo, R., & Muckenthaler, M. U. (2024). Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment. ACS Nano, 18(17), 11025-11041. https://doi.org/10.1021/acsnano.3c08335
Vancouver
Horvat NK, Chocarro S, Marques O, Bauer TA, Qiu R, Diaz-Jimenez A, et al. Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment. ACS Nano. 2024;18(17):11025-11041. doi:10.1021/acsnano.3c08335
BibTeX
@article{Horvat2024,
author = {Horvat, Natalie K and Chocarro, Sara and Marques, Oriana and Bauer, Tobias A and Qiu, Ruiyue and Diaz-Jimenez, Alberto and Helm, Barbara and Chen, Yuanyuan and Sawall, Stefan and Sparla, Richard and Su, Lu and Klingmüller, Ursula and Barz, Matthias and Hentze, Matthias W and Sotillo, Rocío and Muckenthaler, Martina U},
title = {Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {17},
pages = {11025--11041},
doi = {10.1021/acsnano.3c08335}
}
EUVIMED